Standout Papers

MDS clinical diagnostic crit... 1990 2026 2002 2014 4.6k
  1. MDS clinical diagnostic criteria for Parkinson's disease (2015)
    Ronald B. Postuma, Daniela Berg et al. Movement Disorders
  2. Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease (2008)
    Jeffrey H. Kordower, Yaping Chu et al. Nature Medicine
  3. ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASE (1999)
    C. Warren Olanow, W. G. Tatton Annual Review of Neuroscience
  4. A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease (2003)
    C. Warren Olanow, Christopher G. Goetz et al. Annals of Neurology
  5. Variable expression of Parkinson's disease (1990)
    Joseph Jankovic, Michael McDermott et al. Neurology
  6. Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease (2013)
    Jeffrey H. Kordower, C. Warren Olanow et al. Brain
  7. MDS research criteria for prodromal Parkinson's disease (2015)
    Daniela Berg, Ronald B. Postuma et al. Movement Disorders
  8. Oxidative stress and the pathogenesis of Parkinson's disease (1996)
    C. Warren Olanow et al. Neurology
  9. Neuropathological Evidence of Graft Survival and Striatal Reinnervation after the Transplantation of Fetal Mesencephalic Tissue in a Patient with Parkinson's Disease (1995)
    Jeffrey H. Kordower, Thomas B. Freeman et al. New England Journal of Medicine
  10. A radical hypothesis for neurodegeneration (1993)
    C. Warren Olanow Trends in Neurosciences
  11. Pathophysiology of the basal ganglia in Parkinson's disease (2000)
    José Á. Obeso, María Rodríguez‐Oroz et al. Trends in Neurosciences
  12. The scientific and clinical basis for the treatment of Parkinson disease (2009) (2009)
    C. Warren Olanow, Matthew B. Stern et al. Neurology
  13. Understanding cell death in parkinson's disease (1998)
    Peter Jenner, C. Warren Olanow Annals of Neurology
  14. A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease (2009)
    C. Warren Olanow, Olivier Rascol et al. New England Journal of Medicine
  15. Evidence of neuronal oxidative damage in Alzheimer's disease. (1996)
    Paul F. Good, P. Werner et al. PubMed
  16. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study (2013)
    C. Warren Olanow, Karl Kieburtz et al. The Lancet Neurology
  17. Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations (2015)
    Benjamin Dehay, Mathieu Bourdenx et al. The Lancet Neurology

Immediate Impact

6 by Nobel laureates 32 from Science/Nature 161 standout
Sub-graph 1 of 15

Citing Papers

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
2025 StandoutNature
Parkinson’s Disease
2024 Standout
50 intermediate papers

Works of C. Warren Olanow being referenced

MDS clinical diagnostic criteria for Parkinson's disease
2015 Standout
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
2009 Standout
and 46 more

Author Peers

Author Last Decade Papers Cites
C. Warren Olanow 26252 15425 9132 298 39.6k
Étienne C. Hirsch 15962 14921 9145 310 31.3k
Stanley Fahn 24484 13775 5228 487 34.9k
Yves Agid 31073 25204 12797 603 54.2k
Serge Przedborski 21509 15116 14134 257 40.8k
Patrik Brundin 15185 17482 14307 361 34.7k
Peter Jenner 14947 12345 9144 459 30.4k
Niall Quinn 24466 11789 4439 322 31.0k
Peter Riederer 10808 11970 9640 518 34.6k
David Sulzer 10471 14531 10216 247 28.2k
Glenda M. Halliday 29271 13334 10332 645 49.5k

All Works

Loading papers...

Rankless by CCL
2026